Current treatment options in early-onset psychosis

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Standard

Current treatment options in early-onset psychosis. / Pagsberg, Anne Katrine; Melau, Marianne.

Adolescent Psychosis: Clinical and Scientific Perspectives. red. / Ingrid Agartz; Runar Elle Smelror. Elsevier, 2023. s. 273-298.

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Harvard

Pagsberg, AK & Melau, M 2023, Current treatment options in early-onset psychosis. i I Agartz & RE Smelror (red), Adolescent Psychosis: Clinical and Scientific Perspectives. Elsevier, s. 273-298. https://doi.org/10.1016/B978-0-323-89832-4.00002-0

APA

Pagsberg, A. K., & Melau, M. (2023). Current treatment options in early-onset psychosis. I I. Agartz, & R. E. Smelror (red.), Adolescent Psychosis: Clinical and Scientific Perspectives (s. 273-298). Elsevier. https://doi.org/10.1016/B978-0-323-89832-4.00002-0

Vancouver

Pagsberg AK, Melau M. Current treatment options in early-onset psychosis. I Agartz I, Smelror RE, red., Adolescent Psychosis: Clinical and Scientific Perspectives. Elsevier. 2023. s. 273-298 https://doi.org/10.1016/B978-0-323-89832-4.00002-0

Author

Pagsberg, Anne Katrine ; Melau, Marianne. / Current treatment options in early-onset psychosis. Adolescent Psychosis: Clinical and Scientific Perspectives. red. / Ingrid Agartz ; Runar Elle Smelror. Elsevier, 2023. s. 273-298

Bibtex

@inbook{9ea5e928457a4dc29a3b9437016c19f2,
title = "Current treatment options in early-onset psychosis",
abstract = "The recommended treatment for psychosis in adolescents is antipsychotic medication combined with psychosocial interventions. However, the evidence base for especially psychosocial interventions is limited. Compared to adults, fewer antipsychotic medications have been approved for use in youth, who also have a higher risk of a less beneficial response and more side effects. Second-generation antipsychotics are recommended as the first pharmacological choice due to a lower risk of neuromotor and cardiac side effects compared to first-generation antipsychotics. Nevertheless, most second-generation antipsychotics show metabolic side effects. It is recommended that the psychosocial treatment should be managed by a multidisciplinary team working within a specialized early intervention model with focus on: (1) individual and family resources and resilience; (2) individualizing and adjusting the intervention; (3) managing associated comorbidities; (4) ensuring coherence in treatment course and collaborations with social and educational services.",
keywords = "Adolescent psychosis, Antipsychotics, Early-onset schizophrenia, Multidisciplinary treatment team, Psychosocial treatment, Specialized early intervention",
author = "Pagsberg, {Anne Katrine} and Marianne Melau",
note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc. All rights reserved.",
year = "2023",
doi = "10.1016/B978-0-323-89832-4.00002-0",
language = "English",
isbn = "9780323898775",
pages = "273--298",
editor = "Ingrid Agartz and Smelror, {Runar Elle}",
booktitle = "Adolescent Psychosis",
publisher = "Elsevier",

}

RIS

TY - CHAP

T1 - Current treatment options in early-onset psychosis

AU - Pagsberg, Anne Katrine

AU - Melau, Marianne

N1 - Publisher Copyright: © 2023 Elsevier Inc. All rights reserved.

PY - 2023

Y1 - 2023

N2 - The recommended treatment for psychosis in adolescents is antipsychotic medication combined with psychosocial interventions. However, the evidence base for especially psychosocial interventions is limited. Compared to adults, fewer antipsychotic medications have been approved for use in youth, who also have a higher risk of a less beneficial response and more side effects. Second-generation antipsychotics are recommended as the first pharmacological choice due to a lower risk of neuromotor and cardiac side effects compared to first-generation antipsychotics. Nevertheless, most second-generation antipsychotics show metabolic side effects. It is recommended that the psychosocial treatment should be managed by a multidisciplinary team working within a specialized early intervention model with focus on: (1) individual and family resources and resilience; (2) individualizing and adjusting the intervention; (3) managing associated comorbidities; (4) ensuring coherence in treatment course and collaborations with social and educational services.

AB - The recommended treatment for psychosis in adolescents is antipsychotic medication combined with psychosocial interventions. However, the evidence base for especially psychosocial interventions is limited. Compared to adults, fewer antipsychotic medications have been approved for use in youth, who also have a higher risk of a less beneficial response and more side effects. Second-generation antipsychotics are recommended as the first pharmacological choice due to a lower risk of neuromotor and cardiac side effects compared to first-generation antipsychotics. Nevertheless, most second-generation antipsychotics show metabolic side effects. It is recommended that the psychosocial treatment should be managed by a multidisciplinary team working within a specialized early intervention model with focus on: (1) individual and family resources and resilience; (2) individualizing and adjusting the intervention; (3) managing associated comorbidities; (4) ensuring coherence in treatment course and collaborations with social and educational services.

KW - Adolescent psychosis

KW - Antipsychotics

KW - Early-onset schizophrenia

KW - Multidisciplinary treatment team

KW - Psychosocial treatment

KW - Specialized early intervention

U2 - 10.1016/B978-0-323-89832-4.00002-0

DO - 10.1016/B978-0-323-89832-4.00002-0

M3 - Book chapter

AN - SCOPUS:85152850360

SN - 9780323898775

SP - 273

EP - 298

BT - Adolescent Psychosis

A2 - Agartz, Ingrid

A2 - Smelror, Runar Elle

PB - Elsevier

ER -

ID: 367945386